Greater reductions in the levels of antibodies against the acetylcholine receptor (AChR) within the first three months after immunosuppressive…
Marta Figueiredo, PhD
Editorial Associate Director of Resource Pages
Joana holds a BSc in Biology, a MSc in Evolutionary and Developmental Biology, and a PhD in Biomedical Sciences from Universidade de Lisboa, Portugal. Her work has been focused on the impact of non-canonical Wnt signaling in the collective behavior of endothelial cells — those that make up the lining of blood vessels — found in the umbilical cord of newborns. In addition to several research fellowships, she was awarded two Erasmus scholarships to conduct part of her studies in France. She has also authored several research papers published in peer-reviewed international scientific journals. Joana joined Bionews in 2018, starting as a science writer, then moving to a science editor position in 2020, and to editorial associate director of resource pages in 2025.
Education
- PhD, Biomedical Sciences, specialty of Molecular and Cellular Biology
- MSc, Evolutionary and Developmental Biology
- BSc, Biology, speciality Evolutionary and Developmental Biology
Certifications
- ICH Good Clinical Practice E6 (R2)
Published Works
- Non-canonical Wnt signaling regulates junctional mechanocoupling during angiogenic collective cell migration. eLife · 2019
- YAP and TAZ regulate adherens junction dynamics and endothelial cell distribution during vascular development. eLife · 2018
- Endothelial cell dynamics in vascular remodelling. Clinical Hemorheology and Microcirculation · 2016
Professional Accomplishments
- Awarded 2 Erasmus scholarships, several research fellowships, a scholarship conference award, and an honorable mention.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marta Figueiredo, PhD
Myasthenia gravis (MG) crisis, the disease’s most severe state, is associated with pronounced pro-inflammatory cellular and molecular changes, a…
People with rare disorders have a worse healthcare experience than those affected by chronic diseases, according to the results of…
A panel of 16 international experts has updated and expanded the recommendations for best management of myasthenia gravis (MG),…
In people with myasthenia gravis (MG), slow or slurred speech, called dysarthria, is associated with changes in three motor…
The first wave of COVID-19Â in Europe severely disrupted access to care and raised stress and anxiety in people with…
Among myasthenia gravis (MG) patients whose thymomas — tumors of the thymus — are surgically removed, those who are…
Among people with myasthenia gravis (MG) and thymoma — a tumor of the thymus — being male and having…
Argenx’s lead candidate efgartigimod (ARGX-113) safely and effectively eases symptoms in people with generalized myasthenia gravis (gMG) who have…
People who develop ocular myasthenia gravis (OMG) before age 40 are more likely to go into remission after surgery…